Contract

Product Support Specialist

Multiple Teams

Posted on 10/1/2025

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Aberdeen, UK

In Person

Field-based role with 80% travel requirement.

Category
Customer Experience & Support (2)
,
Required Skills
Sales
Data Analysis
Requirements
  • Excellent communication skills with proficiency in spoken and written English
  • Outgoing and persuasive manner and ability to deal with people who hold differing beliefs or values
  • Confidence and persistence
  • Patience and self-motivation
  • Analytical and planning skills
  • Flexible approach to work to adapt to changes
  • Strong teamwork and networking skills
  • Commercial and business awareness
  • Valid driving license
  • Ability and self-confidence to meet the customer on an equal footing to discuss medical and economic issues
  • Sales Skills – challenge the customer
  • Assertiveness
  • Service and solution oriented
  • OR experience
  • Learning skills – Ability to apply new skills at any time. Is open to new ideas
  • Self-employment: High self-organization skills
  • Willingness to travel
  • Positive attitude, a 'can do' solution orientated approach to succeed
  • Self-motivated, you take ownership of your work
  • Collaborative partners, you build and leverage relationships to bring together ideas, data and insights to drive continuous improvements and ultimately to secure wins within your own team as well as in other teams/functions across the business
  • Teamwork is an integral part of this role
  • Goal Orientated, to thrive in this fast-paced environment you will stop at nothing to ensure you achieve your goals, keeping the patient/customer and their requirements squarely in focus, we want people who deliver safe and robust solutions
  • High Ethics & Integrity, we want you to win in the right way, that’s a fundamental building block of Stryker’s vision of being the most admired company in healthcare.
Responsibilities
  • Demonstrates outstanding ethics. Treats customers and employees with respect, represents the company in the best possible light
  • Communicates essential benefits of products and their clinical applications
  • Acts with integrity and reactively delivers on commitments within the required timescales
  • Constructs a basic business plan with input from mentor/manager
  • Daily, weekly, and monthly planning decided in partnership with mentor and RSM
  • Develops rapport. Understands the importance of relationships in selling
  • Using open questioning techniques to ascertain customer's needs and has good working knowledge of key brands to open opportunities for the sales team to sell
  • Uses customer troubleshooting opportunities to grow and protect the business
  • Understands that there are multiple stakeholders in the decision-making process and asks appropriate questions to identify the stakeholders
  • Work is closely supervised, and specific direction provided by more experienced staff
  • Keeps supervisor informed regularly on status of work
  • Failure to achieve results can normally be overcome without serious effect on revenue or budget
  • Achieve sales results in line with the annual sales target and KPI metrics
  • Planning, prioritizing, and executing of required activities and customer support
  • Segmentation of the sales area and define a focus on the expansion of existing customers, as well as support for growing customers together with the Sales Team
  • Support/maintenance of existing customers to maintain customer satisfaction/quality and collaboration with the Sales Team and other departments
  • Development of short and medium-term strategies in collaboration with the customer to secure/strengthen the Stryker position
  • Good communication and negotiation on an equal footing with customers, using reasonable and appropriate methods to ensure a profitable and sustainable relationship
  • Market observations to strengthen own position and constant analysis of responsible area
  • Address challenges with the customer and develop solutions (with support of RSM/Sales Team)
  • Participate in in-house meetings to discuss organizational, development, and business issues and enhance relevant knowledge and skills
  • Administration of IT based customer database/CRM-Tool
  • Serve as front-line clinical and technical support to surgeons and hospital staff before, during and after surgical procedures
  • Train and guide surgeons and hospital staff in the use of Stryker’s Mako robot including set-up, breakdown and related intra-operative activities to ensure precise and successful surgical outcomes
  • Use proprietary software to prepare pre-operative CT scans for assigned cases and assist surgeons in pre-operative implant planning, implant sizing and positioning
  • Troubleshoot and solve technical issues related to the robot independently or field escalation matters appropriately
  • Partner with Field Service team effectively to ensure technical issues are resolved and maintenance is delivered
  • Build knowledge of Stryker implants and instrumentation and mastery of the robot and its different applications in order to become a trusted 'go-to' for all case coverage types (robotic and manual)
  • Educate surgeons and staff on the clinical benefits of the robot and best practices with confidence, enthusiasm and respect
  • Complete Mako 101 and 201 training for all robotic-assisted surgery applications. Obtain certification for each application needed to perform independent case coverage
  • Complete JR 101 and 201 training and develop an understanding of all basic manual procedures
  • Develop ability to competently cover complex primary and revision hip and knee procedures.
Desired Qualifications
  • 0-1 years Sales experience with Diploma in related field
  • Higher Education advantageous
  • Market knowledge and Medical Background preferred
  • First professional experience in sales of capital goods or consumables requiring explanation or many years of experience in clinics / OR

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Robotic surgery leadership drives double-digit sales growth through 2025.
  • India Trident II launch targets aging population's rising hip surgeries.
  • Peripheral vascular expansion via IVL meets growing arterial disease demand.

What critics are saying

  • Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
  • Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
  • J&J Velys captures 25% more knee procedures from Mako in 6-12 months.

What makes Stryker unique

  • Stryker holds 39.1% US market share in orthopedic product manufacturing.
  • Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
  • Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE